piribedil has been researched along with Nausea in 6 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One of these, piribedil, was administered as 0,1 mg/kg intravenously over 30 minutes to 150 subjects with either migraine or other types of headache." | 3.66 | [Value of the piribedil test in diagnosing migraine. Apropos of 150 cases]. ( Bès, A; Courtade, M; Dupui, P; Géraud, G; Guell, A, 1983) |
| "Piribedil is a dopamine agonist acting on D2 and D3 central nervous system dopamine receptors." | 2.70 | Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. ( Allain, H; Bentué-Ferrer, D; Gandon, JM; Kleinermans, D; Polard, E; Reymann, JM; Schück, S, 2002) |
| "Patients with migraine show a hypersensitivity to dopamine or its agonists." | 1.27 | Pharmacological exploration of dopamine hypersensitivity in migraine patients. ( Bès, A; Bessoles, G; Dupui, P; Géraud, G; Güell, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, EK | 1 |
| Ratnagopal, P | 1 |
| Han, SY | 1 |
| Wong, MC | 1 |
| Géraud, G | 2 |
| Bès, A | 2 |
| Courtade, M | 1 |
| Dupui, P | 2 |
| Guell, A | 2 |
| Schück, S | 1 |
| Bentué-Ferrer, D | 1 |
| Kleinermans, D | 1 |
| Reymann, JM | 1 |
| Polard, E | 1 |
| Gandon, JM | 1 |
| Allain, H | 1 |
| Angrist, B | 1 |
| Ain, M | 1 |
| Rotrosen, J | 1 |
| Gershon, S | 1 |
| Halpern, FS | 1 |
| Sachar, EJ | 1 |
| Milliken, JC | 1 |
| Fares, CM | 1 |
| O'Connor, D | 1 |
| Bessoles, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Long-term Therapy With Piribedil (CLARIUM) in Patients With M. Parkinson Under Consideration of Quality of Life Parameters and Cognitive Function[NCT01519856] | 908 participants (Actual) | Observational | 2009-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for piribedil and Nausea
| Article | Year |
|---|---|
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Halluci | 2003 |
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers.
Topics: Adult; Attention; Cognition; Confusion; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; | 2002 |
[Double-blind study on piribedil in peripheral arterial diseases].
Topics: Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Huma | 1976 |
3 other studies available for piribedil and Nausea
| Article | Year |
|---|---|
[Value of the piribedil test in diagnosing migraine. Apropos of 150 cases].
Topics: Adult; Blood Pressure; Diagnosis, Differential; Female; Headache; Humans; Male; Middle Aged; Migrain | 1983 |
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.
Topics: Adult; Dose-Response Relationship, Drug; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Nau | 1979 |
Pharmacological exploration of dopamine hypersensitivity in migraine patients.
Topics: Cerebrovascular Circulation; Domperidone; Dopamine; Headache; Humans; Hypotension; Migraine Disorder | 1986 |